SurModics Inc (SRDX)

[shears]

If this guy is impressed, then maybe we should expect good things?

"I am extremely pleased that SurModics has teamed with Paragon and Apollo to pursue the development and commercialization of this important technology," said Stuart Williams, Ph.D., Scientific Director at the Cardiovascular Innovation Institute in Louisville, Kentucky. "I have been working for over two decades to understand the mechanisms and specific cell types involved in biomaterial healing and applying that knowledge to improve medical devices. In all those years, I have never seen results in stent applications as impressive as those achieved in SurModics' preclinical studies incorporating the FINALE prohealing coating technology."

I read this as an indication that reduction in restenosis may be part of the 'impressive' preclinical results. Perhaps the ECM coating really does inhibit scar tissue as well as promote healing. Why not? Furthermore, a 25% reduction in stent/balloon complex diameter sounds pretty impressive to me. I would surmise that SRDX lubricity will also play a role in the delivery system. SRDX bought an equity stake in the company, as did BSX[guys with a big sales force].

If SRDX truly wants to climb the value chain in the stent market, then an eventual buyout of a company like Apollo (kind of like Innorex) sounds intriguing.

SRDX has a lot of cash.

Just some random thoughts.